The Biggest Psychedelic News Stories of the Week - August 28th

The Biggest Psychedelic News Stories of the Week – August 28th

,
Colorado Advances Psychedelic Legalization with Public Input, Cybin Inc. Acquires Small Pharma, and New Studies Highlight Efficacy of Psilocybin Therapy for Cancer and Depression.
Big Pharma Steps Onto the Psychedelics Wagon

Big Pharma Steps Onto the Psychedelics Wagon

The world of medicine is constantly evolving as more and more research is conducted and breakthroughs are made. One area that has been garnering a lot of attention lately is the use of psychedelics in mental health treatment. And it seems that Big Pharma is taking notice.

The Biggest Psychedelic News Stories of the Week – August 21st

,
Red Light Holland's psilocybin capsules clear stability tests for Australian distribution, as new research explores psychedelics' impact on neural synchronization and consciousness, while Oregon's psilocybin therapy shows promising mental health benefits-but don't expect insurance coverage just yet.
Exclusive: Beckley Waves Establishes Ethics Council to Guide Psychedelic Industry Standards

Exclusive: Beckley Waves Establishes Ethics Council to Guide Psychedelic Industry Standards

,
Beckley Waves has formed a new Ethics Council.
Nonprofit Launches Today to Integrate Psychedelic Therapy with End-of-Life Care

Nonprofit Launches Today to Integrate Psychedelic Therapy with End-of-Life Care

A new psychedelic nonprofit organization called End of Life Psychedelic Care (EOLPC) has been launched this week.
MEAI: The Non-Hallucinogenic Psychedelic with an 'Enough Switch' for Addictions

MEAI: The Non-Hallucinogenic Psychedelic with an ‘Enough Switch’ for Addictions

,
MEAI seems to function like an “enough switch” in the brain, stopping all further desire for alcohol or cocaine and preventing overuse.
The Biggest Psychedelic News Stories of the Week - May 12

The Biggest Psychedelic News Stories of the Week – May 12

,
Vermont and Connecticut take steps towards psilocybin legalization as state representatives discuss how to regulate any potential industry.
MindMed: Can the Former Darlings of the Psychedelic Biotech Sector Avoid Collapse? 

MindMed: Can the Former Darlings of the Psychedelic Biotech Sector Avoid Collapse? 

After MindMed's up-listing, the company has been facing a lot of instability and turbulence in the past few months and years. It has been struggling to establish stability in a sector that is still struggling.
First Patient Dosed in Beckley Psytech’s Phase IIa Study of BPL-003 for Treatment Resistant Depression

First Patient Dosed in Beckley Psytech’s Phase IIa Study of BPL-003 for Treatment Resistant Depression

Beckley Psytech’s Phase IIa study will explore the safety, efficacy and pharmacokinetics of a single dose of BPL-003, in combination with psychological support, in patients with Treatment Resistant Depression (TRD).
Panacea Life Sciences Is Conducting Research for Production on the Most Famous Mushroom: Amanita MuscariaShutterstock: Kateryna Kon

Panacea Life Sciences Is Conducting Research for Production on the Most Famous Mushroom: Amanita Muscaria

,
Panacea Life Sciences is conducting research and formulation design for product development expansion in the fast-growing mushroom category.